Libra Infusions Limited (DSE:LIBRAINFU)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
765.50
-8.40 (-1.09%)
At close: Sep 18, 2025
-1.09%
Market Cap1.71B
Revenue (ttm)197.03M
Net Income (ttm)1.58M
Shares Out2.25M
EPS (ttm)0.70
PE Ratio1,078.97
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,780
Average Volume14,268
Open778.00
Previous Close773.90
Day's Range765.00 - 778.00
52-Week Range687.90 - 1,040.00
Beta-0.39
RSI38.98
Earnings Daten/a

About Libra Infusions

Libra Infusions Limited manufactures and sells injectable intravenous fluids in Bangladesh. Its products are used in medical situations, including diuresis, surgical intervention, intoxication, sodium deficit, infections, and weakness. The company was formerly known as Libra Pharmaceutical Limited and changed its name to Libra Infusions Limited in 1999. Libra Infusions Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 699
Stock Exchange Dhaka Stock Exchange
Ticker Symbol LIBRAINFU
Full Company Profile

Financial Performance

In 2019, Libra Infusions's revenue was 197.03 million, an increase of 3.31% compared to the previous year's 190.72 million. Earnings were 1.58 million, a decrease of -72.49%.

Financial Statements

News

There is no news available yet.